Advertisement

Supplemental Material

The links to relevant recommendations of the American College of Obstetricians and Gynecologists are provided as the primary source of supplemental information to that provided in Clinical Updates in Women's Health Care monographs when applicable. The links to resources other than those of the American College of Obstetricians and Gynecologists are provided for information purposes only, and referral to these resources does not imply the endorsement of the American College of Obstetricians and Gynecologists.

[A]

Adverse Drug Reactions (Vol XIII, No 4)

For clinical guidelines regarding thrombocytopenia in pregnancy, refer to Thrombocytopenia in pregnancy. Practice Bulletin No. 166. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e43-53.

For recommendations on statin use for the prevention of cardiovascular disease, refer to Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr, García FA, et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement. U.S. Preventive Services Task Force. JAMA 2016;316:1997-2007.

Anemia (Vol XI, No 5)

For additional information on patients who refuse blood transfusion, refer to the following documents:

Gupta S, Onwude J, Stasi R, Manyonda I. Refusal of blood transfusion by Jehovah's Witness women: a survey of current management in obstetric and gynaecological practice in the UK. Blood Transfus 2012;10:462-70.

Spahn DR, Goodnough LT. Alternatives to blood transfusion. Lancet 2013;381:1855-65.

Anorectal Disorders (Vol IX, No 1)

Anorectal Disorders, Supplement, Volume IX, Number 1, January 2010 (Reaffirmed 2016)

For clinical guidelines on the management of benign anorectal disorders from the American College of Gastroenterology, refer to Wald A, Bharucha AE, Cosman BC, Whitehead WE. ACG Clinical Guideline: management of benign anorectal disorders. Am J Gastroenterol 2014;109:1141-57.

Autoimmune Disorders (Vol XIII, No 1)

For information on hormone therapy in patients with primary ovarian insufficiency, refer to Hormone therapy in primary ovarian insufficiency. Committee Opinion No. 698. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e134-41.

For clinical guidelines regarding thrombocytopenia in pregnancy, refer to Thrombocytopenia in pregnancy. Practice Bulletin No. 166. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e43-53.

[B]

Benign Breast Disease (Vol XIV, No 3)

For information on hereditary cancer syndromes, refer to Hereditary cancer syndromes and risk assessment. Committee Opinion No. 634. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:1538-43.

For recommendations regarding benign breast disease, refer to Diagnosis and management of benign breast disorders. Practice Bulletin No. 164. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e141-56.

[C]

Care of Aging Women (Vol VIII, No 4)

For information on pap test and mammography guidelines refer to: http://www.acog.org/About_ACOG/ACOG_Departments/Annual_Womens_Health_Care/
Your_Annual_Health_Care_Visit

For a resource from the Joint Commission on falls, refer to Sentinel Event Alert 55: Preventing Falls and Fall-Related Injuries in Health Care Facilities

For Dietary Guidelines for Americans 2015-2020 refer to http://health.gov/dietaryguidelines/2015/guidelines/

Complementary and Alternative Medicine (Vol X, No 4)

For basic information about specific herbs or botanicals refer to: http://nccam.nih.gov/health/herbsataglance.htm

[D]

Dermatoses (Vol VI, No 3)

For current statistics regarding melanoma in the United States refer to http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6421a6.htm?s_cid=mm6421a6_x

[E]

Exercise (Vol XII, No 2)

For a resource from the CDC on CV disease prevention by exercise, refer to Omura JD, Carlson SA, Paul P, Watson KB, Loustalot F, Foltz JL, et al. Adults eligible for cardiovascular disease prevention counseling and participation in aerobic physical activity—United States, 2013. MMWR Morb Mortal Wkly Rep 2015;64:1047-51.

For new information regarding warnings and contraindications to exercise during pregnancy refer to Physical activity and exercise during pregnancy and the postpartum period. Committee Opinion No. 650. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e135-42.

For Dietary Guidelines for Americans 2015-2020 refer to http://health.gov/dietaryguidelines/2015/guidelines/

[G]

Genetics: Counseling, Testing, and Diagnosis (Vol XV, No 2)

For information on counseling about genetic testing and communication of genetic test results, refer to Counseling about genetic testing and communication of genetic test results. Committee Opinion No. 693. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e96-101

For information on carrier screening for genetic conditions, refer to Carrier screening for genetic conditions. Committee Opinion No. 691. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e41-55

For information on carrier screening in the age of genomic medicine, refer to Carrier screening in the age of genomic medicine. Committee Opinion No. 690. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e35-40

For more information on microarrays and next-generation sequencing technology, refer to Microarrays and next-generation sequencing technology: the use of advanced genetic diagnostic tools in obstetrics and gynecology. Committee Opinion No. 682. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e262-8.

For various resources on genetics and genomics compiled by the American College of Obstetrician and Gynecologist's Resource Center refer to: http://www.acog.org/About-ACOG/ACOG-Departments/Resource-Center/WEBTREATS-Genetics-Genomics

Below is the current list of genetics-related guidelines developed by the American College of Obstetricians and Gynecologists:

Genetics and Molecular Diagnostic Testing (Technology Assessment No. 11)

Screening for Fetal Aneuploidy (Practice Bulletin No. 163)

Prenatal Diagnostic Testing for Genetic Disorders (Practice Bulletin No. 162)

Hereditary Breast and Ovarian Cancer Syndrome (Practice Bulletin No. 103)

Lynch Syndrome (Practice Bulletin No. 147)

The Importance of Preconception Care in the Continuum of Women's Health Care (Committee Opinion No. 313)

Perinatal Risks Associated With Assisted Reproductive Technology (Committee Opinion No. 324)

Using Preimplantation Embryos for Research (Committee Opinion No. 347)

Direct-to-Consumer Marketing of Genetic Testing (Committee Opinion No. 409)

Ethical Issues in Genetic Testing (Committee Opinion No. 410)

Family History as a Risk Assessment Tool (Committee Opinion No. 478)

Pharmacogenetics (Committee Opinion No. 488)

Personalized Genomic Testing for Disease Risk (Committee Opinion No. 527)

The Use of Chromosomal Microarray Analysis in Prenatal Diagnosis (Committee Opinion No. 581)

Newborn Screening and the Role of the Obstetrician-Gynecologist (Committee Opinion No. 616)

Hereditary Cancer Syndromes and Risk Assessment (Committee Opinion No. 634)

Cell-free DNA Screening for Fetal Aneuploidy (Committee Opinion No. 640)

Identification and Referral of Maternal Genetic Conditions in Pregnancy (Committee Opinion No. 643)

Gynecologic and Obstetric Care for Breast Cancer Survivors (Vol XVI, No 4)

For additional information on breast cancer risk assessment, refer to Breast cancer risk assessment and screening in average-risk women. Practice Bulletin No. 179. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e1-16.

For additional information on hereditary breast and ovarian cancer syndrome, refer to Hereditary breast and ovarian cancer syndrome. Practice Bulletin No. 103. American College of Obstetricians and Gynecologists. Obstet Gynecol 2009;113:957-66.

For additional information on hereditary cancer syndromes and risk assessment, refer to Hereditary cancer syndromes and risk assessment. Committee Opinion No. 634. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:1538-43.

For additional information on osteoporosis, refer to Osteoporosis. Practice Bulletin No. 129. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:718-34.

[H]

Hormone Therapy and Alternative Therapies for Menopause (Vol XIV, No 4)

For The 2017 Hormone Therapy Position Statement of The North American Menopause Society, refer to http://journals.lww.com/menopausejournal/Abstract/2017/07000/The_2017_
hormone_therapy_position_statement_of_The.5.aspx

For information on hormone therapy in patients with primary ovarian insufficiency, refer to Hormone therapy in primary ovarian insufficiency. Committee Opinion No. 698. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e134-41.

For information on pap test and mammography guidelines refer to: http://www.acog.org/About_ACOG/ACOG_Departments/Annual_Womens_Health_Care/ Your_Annual_Health_Care_Visit

For the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines refer to: http://circ.ahajournals.org/content/early/2013/11/11/01.cir.0000437741.48606.98

For information on dietary reference intakes for calcium and vitamin D refer to: https://iom.nationalacademies.org/~/media/Files/ReportFiles/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/Vitamin D and Calcium 2010 Report Brief.pdf

For a complete listing of the College's resources on menopause refer to http://www.acog.org/Womens-Health/Menopause

For a complete listing of the College's resources on hormone therapy refer to http://www.acog.org/Womens-Health/Hormone-Therapy

Hypertension (Vol XV, No 1)

For additional information on severe hypertension, refer to Bernstein PS, Martin JN Jr, Barton JR, Shields LE, Druzin ML, Scavone BM, et al. National Partnership for Maternal Safety: consensus bundle on severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2017;130:347-57.

For information on emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period, refer to Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Committee Opinion No. 692. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017:129:e90-5.

For 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8) refer to: http://jama.jamanetwork.com/article.aspx?articleid=1791497

For information on hypertension-related mortality in the United States in 2000-2013 refer to http://www.cdc.gov/nchs/data/databriefs/db193.htm

For additional information on preeclampsia, refer to First-trimester risk assessment for early-onset preeclampsia. Committee Opinion No. 638. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e25-7.

For the AGOG Practice Advisory on Low-Dose Aspirin and Prevention of Preeclampsia, refer to http://www.acog.org/About-ACOG/News-Room/Practice-Advisories/Practice-Advisory-Low-Dose-Aspirin-and-Prevention-of-Preeclampsia-Updated-Recommendations

[L]

Liver Disease: General Pathophysiology, Diagnosis, and Management (Vol XV, No 6)

Liver Disease: General Pathophysiology, Diagnosis, and Management, Supplement, Volume XV, Number 6, November 2016

Liver Disease: Reproductive Considerations (Vol XVI, No 1)

For ACOG guidelines on HPV vaccinations, refer to Human papillomavirus vaccination. Committee Opinion No. 704. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e173-8.

Below is the current list of guidelines developed by the American College of Obstetricians and Gynecologists that relate to various aspects of liver disease in reproductive-aged and postmenopausal women:

Nausea and vomiting of pregnancy. Practice Bulletin No. 153. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e12-24.

American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Washington, DC: American College of Obstetricians and Gynecologists; 2013.

Viral hepatitis in pregnancy. ACOG Practice Bulletin No. 86. American College of Obstetricians and Gynecologists. Obstet Gynecol 2007;110:941-56.

Cervical cancer screening and prevention. Practice Bulletin No. 168. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;128:e111-30.

Diagnosis of abnormal uterine bleeding in reproductive-aged women. Practice Bulletin No. 128. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:197-206.

Noncontraceptive uses of hormonal contraceptives. Practice Bulletin No. 110. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;115:206-18.

Management of menopausal symptoms. Practice Bulletin No. 141. American College of Obstetricians and Gynecologists. Obstet Gynecol 2014;123:202-16.

Osteoporosis. Practice Bulletin No. 129. American College of Obstetricians and Gynecologists. Obstet Gynecol 2012;120:718-34.

Lower Gastrointestinal Tract Disorders (Vol XIV, No 5)

For USPSTF recommendation on screening for celiac disease, refer to Bibbins-Domingo K, Grossman DC, Curry SJ, Barry MJ, Davidson KW, Doubeni CA, et al. Screening for celiac disease: US Preventive Services Task Force Recommendation Statement. US Preventive Services Task Force. JAMA 2017;317:1252-7.

[M]

Metabolic Bone Disease (Vol XIV, No 2)

For a resource from the NIH on vitamin D supplementation refer to Fact Sheet for Health Professionals: Vitamin D

For Dietary Guidelines for Americans 2015-2020 refer to http://health.gov/dietaryguidelines/2015/guidelines/

For recommendations regarding aromatase inhibitors in GYN practice, refer to Aromatase inhibitors in gynecologic practice. Committee Opinion No. 663. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e170-4.

Mood and Anxiety Disorders (Vol XVI, No 5)

For additional information on mental health disorders in adolescents, refer to Mental health disorders in adolescents. Committee Opinion No. 705. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e32-41.

For a compilation of resources on mental health disorders in adolescents, refer to https://www.acog.org/Womens-Health/Mental-Health-Disorders-in-Adolescents.

For additional information on screening for perinatal depression, refer to Screening for perinatal depression. Committee Opinion No. 630. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:1268-71.

For additional information on the use of psychiatric medications during pregnancy and lactation, refer to Use of psychiatric medications during pregnancy and lactation. ACOG Practice Bulletin No. 92. American College of Obstetricians and Gynecologists. Obstet Gynecol 2008;111:1001-20.

For additional information on noncontraceptive uses of hormonal contraceptives, refer to Noncontraceptive uses of hormonal contraceptives. Practice Bulletin No. 110. American College of Obstetricians and Gynecologists. Obstet Gynecol 2010;115:206-18.

For additional resources on depression and postpartum depression, refer to https://www.acog.org/Womens-Health/Depression-and-Postpartum-Depression.

For a compilation of web sites related to depression and postpartum depression, refer to https://www.acog.org/About-ACOG/ACOG-Departments/Resource-Center/WEBTREATS-Depression-Resources.

For information on opioid use and opioid use disorder in pregnancy, refer to Opioid use and opioid use disorder in pregnancy. Committee Opinion No. 711. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e81-94.

[N]

Nutrition (Vol XIII, No 3)

For information on listeria refer to: Management of pregnant women with presumptive exposure to Listeria monocytogenes. Committee Opinion No. 614. American College of Obstetricians and Gynecologists. Obstet Gynecol 2014;124:1241-4.

For a resource from the NIH on vitamin D supplementation refer to Fact Sheet for Health Professionals: Vitamin D

For new information regarding warnings and contraindications to exercise during pregnancy refer to Physical activity and exercise during pregnancy and the postpartum period. Committee Opinion No. 650. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e135-42.

For Dietary Guidelines for Americans 2015-2020 refer to http://health.gov/dietaryguidelines/2015/guidelines/

For information on seafood consumption during pregnancy, refer to the ACOG Practice Advisory: Update on Seafood Consumption During Pregnancy at http://www.acog.org/About-ACOG/News-Room/Practice-Advisories/ACOG-Practice-Advisory-Seafood-Consumption-During-Pregnancy

[O]

Obesity (Vol XII, No 1)

For information on ethical issues in the care of the obese woman refer to: Ethical Issues in the Care of the Obese Woman. Committee Opinion No. 600. American College of Obstetricians and Gynecologists.

For The Obesity Society, American College of Cardiology, and American Heart Association guidelines on management of obesity, go to Guidelines (2013) for Managing Overweight and Obesity in Adults

For information regarding a treatment option for long-term weight management refer to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427913.htm

For information on gynecologic surgery in the obese woman refer to: Gynecologic surgery in the obese woman. Committee Opinion No. 619. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:274-8.

For new information on obesity in pregnancy refer to Obesity in pregnancy. Practice Bulletin No. 156. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e112-26.

For new information regarding warnings and contraindications to exercise during pregnancy refer to Physical activity and exercise during pregnancy and the postpartum period. Committee Opinion No. 650. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e135-42.

For Dietary Guidelines for Americans 2015-2020 refer to http://health.gov/dietaryguidelines/2015/guidelines/

For current prepregnancy BMI data from the Centers for Disease Control and Prevention, refer to Prepregnancy Body Mass Index by Maternal Characteristics and State: Data From the Birth Certificate, 2014.

For a position statement on adolescent obesity from the Society for Adolescent Health and Medicine, refer to Society for Adolescent Health and Medicine. Preventing and treating adolescent obesity: a position paper of the Society for Adolescent Health and Medicine. J Adolesc Health 2016;59:602-6.

Occupational Diseases and Injuries (Vol IX, No 3)

For related information on exposure to toxic environmental agents refer to:

http://www.acog.org/Resources_And_Publications/Committee_Opinions
/Committee_on_Health_Care_for_Underserved_Women
/Exposure_to_Toxic_Environmental_Agents


http://www.acog.org/About_ACOG/ACOG_Departments/Health_Care_for_Underserved_
Women/~/media/Committee%20Opinions/Committee%20on%20Health%20Care%20for
%20Underserved%20Women/ExposuretoToxic.pdf

[P]

Polycystic Ovary Syndrome (Vol XV, No 4)

For the latest resources on evaluation, management, and health care needs, of patients with polycystic ovary syndrome, refer to the Centre for Research Excellence in Polycystic Ovary Syndrome.

Perioperative Considerations for Coexisting Medical Conditions (Vol IX, No 4)

For Practice Guidelines for Postanesthetic Care refer to: http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1918686

For 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines refer to: http://circ.ahajournals.org/content/early/2014/07/31/CIR.0000000000000106.full.pdf

For information on chronic antithrombotic therapy and gynecologic surgery refer to: http://www.acog.org/Resources-And-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/Chronic-Antithrombotic-Therapy-and-Gynecologic-Surgery

[R]

Renal Disease (Vol X, No 1)

For Consumer fact sheet on screening for chronic renal disease from the U.S. Preventive Services Task Force refer to: http://www.uspreventiveservicestaskforce.org/uspstf12/kidney/ckdfact.pdf

[S]

Sexuality and Sexual Disorders (Vol XIII, No 2)

For additional information on sexual health, refer to Sexual health. Committee Opinion No. 706. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;130:e42-7.

For information on testosterone therapy in female sexual dysfunction refer to: Androgen Therapy: A Reappraisal: An Endocrine Society Clinical Practice Guideline.

For a compilation of resources on sex and sexuality prepared by the ACOG Resource Center, refer to http://www.acog.org/About_ACOG/ACOG_Departments
/Resource_Center/WEBTREATS_Sex_and_Sexuality

Sleep Disorders (Vol XI, No 3)

For current patient information from the American Sleep Apnea Association, refer to http://sleepapnea.org/index.html

For information regarding a treatment option for insomnia refer to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm409950.htm

[T]

Thyroid Disorders (Vol XII, No 5)

For information regarding thyroid disease in pregnancy refer to Thyroid disease in pregnancy. Practice Bulletin No. 148. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015; 125:996 -1005.

[U]

Upper Gastrointestinal Tract, Biliary, and Pancreatic Disorders (Vol XI, No 4)

For additional information on nausea and vomiting during pregnancy, refer to Nausea and vomiting of pregnancy. Practice Bulletin No. 153. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;126:e12-24.

For the National Institute for Health and Care Excellence guidelines for cancer recognition and referral go to http://www.nice.org.uk/guidance/NG12/chapter/1-recommendations.

[V]

Vulvar Disorders (Vol VIII, No 2)

For ACOG guidelines on HPV vaccinations, refer to Human papillomavirus vaccination. Committee Opinion No. 704. American College of Obstetricians and Gynecologists. Obstet Gynecol 2017;129:e173-8.

 




Editor
Russell R. Snyder, MD

Associate Editor
Gretchen M. Lentz, MD

Past Editor
Raul Artal, MD

ISSN 1536-3619
Published 6 times per year